Combination therapy

Details for Australian Patent Application No. 2005225193 (hide)

Owner AstraZeneca AB

Inventors Wedge, Stephen Robert

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005225193

PCT Pub. Number WO2005/092303

Priority 0406446.5 23.03.04 GB

Filing date 22 March 2005

Wipo publication date 6 October 2005

Acceptance publication date 9 October 2008

International Classifications

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/4745 (2006.01)

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/092303 Priority application(s): WO2005/092303

9 October 2008 Application Accepted

  Published as AU-B-2005225193

5 February 2009 Standard Patent Sealed

18 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005225197-Combination therapy

2005225192-Combination therapy